EUROpean network for transnational collaborative RTD projects in the field of NANOMEDicine

Basic Information


Nanomedicine, the application of nanotechnology to health, is a fast-growing field with a large potential for improving diagnostics and therapeutic solutions in many diseases. The EuroNanoMed II (ENM II) consortium, with 20 partners from 17 countries and regions, aims to foster the competitiveness of European nanomedicine actors through the support of translational research projects enhancing transnational and multidisciplinary collaborations between academia, clinical/public health communities and industry. ENM II will be a follow-up of the ERA-NET EuroNanoMed I (ENM I), which launched three joint transnational calls for proposals in three years. The increasing number of submitted proposals in the successive ENM I joint calls and their quality show the need amongst the nanomedicine scientific community for such a targeted initiative. ENM II will be built on the basis of the ENM I accomplishments, and will continue to support transnational innovative RTD projects in nanomedicine through the launch of yearly joint calls for proposals. In addition, ENM II aims to extend the cooperation among its partners through the development of other activities: (i) Foster the participation of young European researchers to ENM II activities; ii) Develop a strategic agenda for ENM II in close cooperation to the ETP Nanomedicine; iii) Create more interactions within the European nanomedicine community and improve communication on nanomedicine to the public; iv) Frame and address regulatory, safety and ethical issues associated with nanomedicine; v) Monitor the results of the ENM I & ENM II funded research projects and the activities of the ENM II network; vi) Develop a long-term cooperation framework for European nanomedicine research. Therefore, through joint funding of translational nanomedicine projects and its other activities, ENM II will contribute to enhance coordination of research and resources in this field, thereby shaping the European Research Area in nanomedicine.

Research fields covered by the network

  • Materials
  • Nanosciences and nanotechnologies
  • Health

Target Groups

  • Private and Semi-private Research and Technology Organisations (RTOs)
  • Higher Education Institutions (HEIs)
  • Public Research Organisations (PROs)
  • Large Corporations
  • SME (Small and Medium Enterprises)

Is connected with

Show on map



Joint Calls

Joint Call Title Type Launch Date Deadline
End Date
7th Joint Transnational Call for Proposals (2016) for European Innovative Research & Technological Development Projects in Nanomedicine one-stage 26/11/2015   11/02/2016  
JTC2015 one-stage 26/11/2014   03/03/2015

Submitted: 66


Funded: 11

JTC2014 one-stage 26/11/2013   04/03/2014

Submitted: 51


Funded: 9

JTC2013 one-stage 01/01/2013   04/03/2013

Submitted: 43


Funded: 8